K562mb15-41BBL is a myeloid leukemia cell line that is genetically modified to express membrane-bound interleukin-15 and 41BB ligands in order to specifically activate NK cells but not T lymphocytes. The gene discussed is IL15; the disease is myeloid leukemia.